IL17A and rheumatoid arthritis: The osteoclast, which plays a critical role in the initiation of joint and bone erosion in RA, is a known target of numerous cytokines, including ones that are osteoclastogenic (e.g., IL-1 and IL-17) and others that are anti-osteoclastogenic (e.g., IL-4) [28].